139 related articles for article (PubMed ID: 16706365)
21. Scutellarin-cyclodextrin conjugates: synthesis, characterization and anticancer activity.
Yang B; Zhao YL; Yang X; Liao XL; Yang J; Zhang JH; Gao CZ
Carbohydr Polym; 2013 Feb; 92(2):1308-14. PubMed ID: 23399159
[TBL] [Abstract][Full Text] [Related]
22. Polyethylene glycol 900 permeability of rat intestinal and colonic segments in vivo and brush border membrane vesicles in vitro.
Hollander D; Koyama S; Dadufalza V; Tran DQ; Krugliak P; Ma T; Ling KY
J Lab Clin Med; 1989 Apr; 113(4):505-15. PubMed ID: 2703761
[TBL] [Abstract][Full Text] [Related]
23. Study on the role of hepatic first-pass elimination in the low oral bioavailability of scutellarin in rats.
Hao X; Cheng G; Yu JE; He Y; An F; Sun J; Cui F
Pharmazie; 2005 Jun; 60(6):477-8. PubMed ID: 15997843
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacokinetic and tissue distribution study of scutellarin in rats].
You HS; Dong YL; Xing JF; Zhang CL; Wang MY
Zhongguo Zhong Yao Za Zhi; 2007 Aug; 32(16):1688-92. PubMed ID: 18027669
[TBL] [Abstract][Full Text] [Related]
25. Nanosuspension development of scutellarein as an active and rapid orally absorbed precursor of its BCS class IV glycoside scutellarin.
Yang X; Miao X; Cao F; Li S; Ai N; Chang Q; Lee SMY; Zheng Y
J Pharm Sci; 2014 Nov; 103(11):3576-3584. PubMed ID: 25187229
[TBL] [Abstract][Full Text] [Related]
26. Metabolic and pharmacokinetic studies of scutellarin in rat plasma, urine, and feces.
Xing JF; You HS; Dong YL; Lu J; Chen SY; Zhu HF; Dong Q; Wang MY; Dong WH
Acta Pharmacol Sin; 2011 May; 32(5):655-63. PubMed ID: 21516133
[TBL] [Abstract][Full Text] [Related]
27. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study.
Zabaleta V; Ponchel G; Salman H; Agüeros M; Vauthier C; Irache JM
Eur J Pharm Biopharm; 2012 Aug; 81(3):514-23. PubMed ID: 22516136
[TBL] [Abstract][Full Text] [Related]
28. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). I. Chemical analysis and biological properties of PEG 400.
Chadwick VS; Phillips SF; Hofmann AF
Gastroenterology; 1977 Aug; 73(2):241-6. PubMed ID: 873124
[TBL] [Abstract][Full Text] [Related]
29. Small intestinal absorption of polyethylene glycol 400 to 1,000 in the portacaval shunted rat.
Pantzar N; Bergqvist PB; Bugge M; Olaison G; Lundin S; Jeppsson B; Weström B; Bengtsson F
Hepatology; 1995 Apr; 21(4):1167-73. PubMed ID: 7705792
[TBL] [Abstract][Full Text] [Related]
30. Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies.
Shen Q; Li W; Lin Y; Katsumi H; Okada N; Sakane T; Fujita T; Yamamoto A
J Pharm Pharmacol; 2008 Dec; 60(12):1633-41. PubMed ID: 19000368
[TBL] [Abstract][Full Text] [Related]
31. Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of poly(ethylene glycol) and D-peptides.
He YL; Murby S; Warhurst G; Gifford L; Walker D; Ayrton J; Eastmond R; Rowland M
J Pharm Sci; 1998 May; 87(5):626-33. PubMed ID: 9572915
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous determination of scutellarin and tetrahydropalmatine of Deng-yan granule in rat plasma by UFLC-MS/MS and its application to a pharmacokinetic study.
Zhang X; Guan J; Zhu H; Niu T
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 971():126-32. PubMed ID: 25289789
[TBL] [Abstract][Full Text] [Related]
33. β-Glucuronidase- and OATP2B1-mediated drug interaction of scutellarin in Dengzhan Xixin Injection: A formulation aspect.
Shi J; Sun C; Huang H; Lin W; Gao J; Lin Y; Zhang Z; Huo X; Tian X; Yu Z; Zhang B; Ma X
Drug Dev Res; 2020 Aug; 81(5):609-619. PubMed ID: 32220026
[TBL] [Abstract][Full Text] [Related]
34. Sustained release and enhanced bioavailability of injectable scutellarin-loaded bovine serum albumin nanoparticles.
Wei Y; Li L; Xi Y; Qian S; Gao Y; Zhang J
Int J Pharm; 2014 Dec; 476(1-2):142-8. PubMed ID: 25269007
[TBL] [Abstract][Full Text] [Related]
35. Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies.
Shen Q; Lin Y; Handa T; Doi M; Sugie M; Wakayama K; Okada N; Fujita T; Yamamoto A
Int J Pharm; 2006 Apr; 313(1-2):49-56. PubMed ID: 16500056
[TBL] [Abstract][Full Text] [Related]
36. Influence of the gastrointestinal microflora and efflux transporters on the absorption of scutellarin and scutellarein.
You HS; Xing JF; Lu J; Dong WH; Liu JT; Dong YL
Phytother Res; 2014 Sep; 28(9):1295-300. PubMed ID: 24504668
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and metabolism of the flavonoid scutellarin in humans after a single oral administration.
Chen X; Cui L; Duan X; Ma B; Zhong D
Drug Metab Dispos; 2006 Aug; 34(8):1345-52. PubMed ID: 16714374
[TBL] [Abstract][Full Text] [Related]
38. A study on distribution and stability of drugs at the interface of a scutellarin-loaded emulsion.
Ma M; Huang S; Zhu J; Xiong F
Pharm Dev Technol; 2021 Sep; 26(7):740-749. PubMed ID: 34182861
[TBL] [Abstract][Full Text] [Related]
39. Water-soluble gambogic acid PEGylated prodrugs: synthesis, characterization, physicochemical properties and in vitro hydrolysis.
Tang X; Zhang P; Ye H; Zhang C; Shen W; Ping Q
Pharmazie; 2008 Oct; 63(10):711-7. PubMed ID: 18972831
[TBL] [Abstract][Full Text] [Related]
40. Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree.
Prego C; Torres D; Fernandez-Megia E; Novoa-Carballal R; Quiñoá E; Alonso MJ
J Control Release; 2006 Apr; 111(3):299-308. PubMed ID: 16481062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
